U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C23H31ClN2O3.2C4H4O4
Molecular Weight 651.101
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 2
Charge 0

SHOW SMILES / InChI
Structure of ETODROXIZINE DIMALEATE

SMILES

OC(=O)\C=C/C(O)=O.OC(=O)\C=C/C(O)=O.OCCOCCOCCN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(Cl)C=C3

InChI

InChIKey=LCTVSMAEOLQJSR-SPIKMXEPSA-N
InChI=1S/C23H31ClN2O3.2C4H4O4/c24-22-8-6-21(7-9-22)23(20-4-2-1-3-5-20)26-12-10-25(11-13-26)14-16-28-18-19-29-17-15-27;2*5-3(6)1-2-4(7)8/h1-9,23,27H,10-19H2;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1-

HIDE SMILES / InChI

Description

Etodroxizine is a first-generation antihistamine of the diphenylmethane and piperazine classes. It is a sleep-inducing agent. Etodroxizine in combination with methaqualone had a somewhat stronger surpressive effect upon REM-sleep than methaqualone alone.

Approval Year

Unknown
139594
Name Type Language
ETODROXIZINE DIMALEATE
MI   WHO-DD  
Common Name English
ETHANOL, 2-(2-(2-(4-((4-CHLOROPHENYL)PHENYLMETHYL)-1-PIPERAZINYL)ETHOXY)ETHOXY)-, (Z)-2-BUTENEDIOATE (1:2) (SALT)
Common Name English
DRIMYL
Brand Name English
NOXADRON
Brand Name English
INDUNOX
Brand Name English
Etodroxizine dimaleate [WHO-DD]
Common Name English
ETHANOL, 2-(2-(2-(4-((4-CHLOROPHENYL)PHENYLMETHYL)-1-PIPERAZINYL)ETHOXY)ETHOXY)-, (2Z)-2-BUTENEDIOATE (1:2) (SALT)
Common Name English
ETODROXIZINE DIMALEATE [MI]
Common Name English
U. C. B. 1414
Code English
Code System Code Type Description
PUBCHEM
20840398
Created by admin on Fri Dec 15 18:44:16 GMT 2023 , Edited by admin on Fri Dec 15 18:44:16 GMT 2023
PRIMARY
FDA UNII
O9NQM95R01
Created by admin on Fri Dec 15 18:44:16 GMT 2023 , Edited by admin on Fri Dec 15 18:44:16 GMT 2023
PRIMARY
MERCK INDEX
m726
Created by admin on Fri Dec 15 18:44:16 GMT 2023 , Edited by admin on Fri Dec 15 18:44:16 GMT 2023
PRIMARY Merck Index
CAS
56335-21-8
Created by admin on Fri Dec 15 18:44:16 GMT 2023 , Edited by admin on Fri Dec 15 18:44:16 GMT 2023
PRIMARY
ACTIVE MOIETY
Structure of ETODROXIZINE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966